Raul Gonzalez, Ph.D
Total Page:16
File Type:pdf, Size:1020Kb
Revised: 01.20.2021 Raul Gonzalez, Ph.D. PROFESSOR OF PSYCHOLOGY, PSYCHIATRY, AND IMMUNOLOGY FLORIDA INTERNATIONAL UNIVERSITY SUBSTANCE USE NEUROPSYCHOLOGY LABORATORY SUN LAB CONTACT INFORMATION Florida International University Voice 305.348.4921 Center for Children and Families Fax 305.348.7456 AHC-4, Room 461 [email protected] th 11200 SW 8 Street http://sunlab.fiu.edu Miami, FL 33199 https://scholar.google.com/citations?user=cG- 26IIAAAAJ APPOINTMENTS 2017 – P Professor of Psychology (secondary appointments in Psychiatry and Immunology, FIU Wertheim College of Medicine) Florida International University, Miami, Department of Psychology 2014 – 2017 Associate Professor of Psychiatry and Immunology (secondary appointments) Florida International University, Miami, Herbert Wertheim College of Medicine 2012 – 2017 Associate Professor of Psychology (Tenured), Director of SUHN Lab Florida International University, Miami, Department of Psychology 2010 – 2012 Assistant Professor of Psychology (secondary appointment) University of Illinois, Chicago, Department of Psychology 2006 – 2012 Assistant Professor of Psychiatry (Tenure Track) University of Illinois, Chicago, Department of Psychiatry LICENSURE 2014 – P Licensed Clinical Psychologist State of Florida 2006 – 2016 Licensed Clinical Psychologist [inactive] State of Illinois EDUCATION 2004 – 2006 Post-doctoral Research Fellow in Neuropsychology, Cognitive & Addictions Neuroscience University of Illinois, Chicago, Department of Psychiatry Fulfills INS/Divison40 postdoctoral training guidelines in clinical neuropsychology Gonzalez, R. 1 Revised: 01.20.2021 2003 – 2004 Clinical Psychology Internship University of Illinois, Chicago, Department of Psychiatry APA-accredited internship; APCS Member Program 1998 – 2004 Ph.D. in Clinical Psychology (Neuropsychology track) San Diego State University / University of California, San Diego UCSD, Department of Psychiatry & SDSU, Department of Psychology APA-accredited doctoral program; APCS Member Program 1998 – 2002 M.S. in Clinical Psychology (Neuropsychology track) San Diego State University / University of California, San Diego UCSD, Department of Psychiatry & SDSU, Department of Psychology APA-accredited doctoral program; APCS Member Program 1995 - 1997 B.A. in Psychology, minor in Chemistry, magna cum laude, Honors College Florida International University, Miami, FL, College of Arts & Sciences RESEARCH FUNDING AWARDED (ACTIVE) 2020 – 2027 “ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT FIU” $13.9 million Principal Investigator (Co-PI: Laird) NIH/NIDA 2U01 DA041156 2020 – 2024 “Effects of Cannabis on Cardiovascular and Cardiometabolic Disease Risk” $2.9 million Co-Investigator (PI: Vidot) NHLBI R01HL153467 2017 – 2022 “FIU Center for Reducing Disparities in Substance Abuse & HIV in South Florida” $16.1 million Co-Investigator (PI: Wagner) NIH/NIMHH U54 MD012393 2015 – 2020 “MRI: Development of an integrated neuroimaging instrument with temporal and spatial alignments for brain research. (NCE) $3.8 million Co-investigator (PI: Malek) NSF/CNS CNS-1532061 AWARDED (COMPLETED) 2015 – 2020 “Nano-delivery of methanandamide across BBB to block cannabinoid induced effects in HIV-1 infection” $2.9 million Co-investigator (PI: Nair) NIH/NIDA R01 DA40537 2015 – 2020 “Adolescent Brain Cognitive Development (ABCD): FIU” $12.7 million Principal Investigator NIH/NIDA U01 DA041156 2018 – 2019 “Leveraging the ABCD study to examine the effects of Hurricane Irma exposure: the disaster and youth, neural, and affective maturation in context (DYNAMIC) study. $179,982 Co-investigator (PI: Dick, Comer) NSF RAPID BCS1805645 2012 – 2019 "The impact of cannabis use on the neuropsychological functioning of individuals with HIV/AIDS" $2.2 million Principal Investigator NIH/NIDA R01 DA033156 Gonzalez, R. 2 Revised: 01.20.2021 2012 – 2019 "Decision-making and episodic memory in trajectories to cannabis addiction" $2.2 million Principal Investigator NIH/NIDA R01 DA031176 2017 – 2018 “The joint effect of neighborhood-level factors and decision-making on changes in cannabis use” $99,847 total costs Principal Investigator [mentor] NIH/NIDA R01 DA031176-S1 2012 – 2017 "Cognitive neuropsychology of HIV and drug abuse" Co-Investigator (PI: Martin) NIH/NIDA R01 DA012828-11 *Role changed to consultant after change of institution 2012 – 2014 “Administrative supplement: Social-emotional contexts of adolescent smoking patterns” Co-Investigator (PI: Mermelstein) NIH/NCI Supplement to P01 CA098262 *Role changed to consultant after change of institution 2008 – 2012 "Neurocognitive disinhibition and cannabis addiction" $476,184 Principal Investigator NIH/NIDA K23 DA023560 2007 – 2008 "Executive function and alcohol use: precursors and consequences" Co-Investigator (PI: Kassel) University of Illinois Chicago Institute for Health Research and Policy (IHRP) Pilot Grant Program 2006 – 2008 "Cognitive neuropsychology of HIV and drug abuse" Co-Investigator (PI: Martin) NIH/NIDA R01 DA012828-06 2005 – 2007 "Drug Addiction, HIV, and neurocognitive functioning" [loan repayment] Principal Investigator NIH/NIDA L30 DA018528 NIH Clinical Research Loan Repayment Program (Competitive Renewal) 2005 -2007 "Mechanisms for neurocognitive damage of HIV+ drug users" $86,044 Principal Investigator NIH/NIDA F32 DA018522 Ruth L. Kirschstein National Research Service Award (NRSA) 2000 – 2003 “Neurocognitive effects of combined methamphetamine and alcohol abuse” Principal Investigator NIH/NIDA Supplement to P01 DA12065 Grant Supplement for Underrepresented Minorities HONORS, AWARDS, & RECOGNITIONS 1998 – 2000 San Diego Fellowship, UCSD 2006 APA 2006 NIDA Early Career Investigator Invited Travel Award 2006 NIDA Research Training Institute Invited Travel Award 2007 APA 2007 NIDA Early Career Investigator Invited Travel Award 2010 Center for Clinical and Translational Science Mentor Academy Stipend 2012 UIC Faculty Scholarship Support Program Award 2013 NIDA DCNBR Outstanding Early Career Investigator Award 2013 Florida International University Top Scholar 2016 Florida International University Top Scholar 2016 Florida International University Faculty Senate Award for Excellence in Research and Creative Activities 2016 Florida International University College of Arts and Sciences Faculty Award – Research Gonzalez, R. 3 Revised: 01.20.2021 PUBLICATIONS CITATION METRICS (Based only on publications with data on Google Scholar) http://scholar.google.com/citations?user=cG-26IIAAAAJ&hl=en Times cited: 6042 h-index: 38 i10-index: 68 i100-index: 18 BOOK CHAPTERS 1. Gonzalez, R., Martin, E.M., & Grant, I. (2007). Marijuana. In Kalechstein, A. & Van Gorp, W. (Eds.). Neuropsychology and Substance Use: State of the Art and Future Directions. New York: Taylor and Francis, 139 – 170. 2. Gonzalez, R., Vassileva, J., Scott, J.C. (2009). Neuropsychological Consequences of Drug Abuse. In Grant, I. & Adams, K.M. (Eds.), Neuropsychological Assessment of Neuropsychiatric Disorders, 3rd Edition. New York: Oxford University Press, 455 – 479. 3. Gonzalez, R., Quartana, Phillip J., Martin, E. M. (2009). Co-occurrence of HIV, Hepatitis C, and Substance Use Disorders: Effects on Brain Functioning. In Paul, R.H., Sacktor, N.C., Valcour, V., & Tashima, K.T. (Eds.) HIV and the Brain: New Challenges in the Modern Era. New York: Humana Press, 213 – 232. 4. Levine, A., Gonzalez, R., Martin, E.M. (2012). Neurocognition in HIV and Substance Use Disorders. In Gendelman, H.E., Grant, I., Everall, I.P., Gelbard, H.A., Fox, H.S., Lipton, S.A., and Swindells, S. (Eds.) The Neurology of AIDS, Third Edition. New York: Oxford University Press, 1034 – 1044. 5. Levine, A.J., Ross, J.M., Gonzalez, R., Martin, M. (2015). Neurocognitive functioning in HIV-infected substance users. In Hope, T.J., Stevenson, M., and Richman, D. (Eds.) Encyclopedia of AIDS. New York: Springer, 1-8. 6. *Pacheco-Colon, I., Duperrouzel, J., Gonzalez, R. (2018). Studies in cannabis use. In Koffler, S, Mahone, M.E., Marcopulos, B.A., Johnson-Greene, D.E., Smith, G. (eds.) “Neuropsychology: Science and Practice v3.” Oxford University Press. 7. *Pacheco-Colon, I. & Gonzalez, R. (2020). Cognitive sequelae of cannabis use. In Verdejo-Garcia, A. (ed.) “Cognition and Addiction: A researcher’s guide from mechanisms towards interventions. Academic Press. 8. *Ross, J.M., Duperrouzel, J.C., Pacheco-Colón, I., Gonzalez, R. (2020). Psychosocial: Substance Abuse – Street Drugs. In Paul, R.H., Saliminen, L.E., Heaps, J., Cohen, L.M. (eds.) The Wiley Encyclopedia of Health Behaviors. Wiley & Sons, 261-273. REVIEW ARTICLES AND COMMENTARIES 1. Gonzalez, R., Carey, C., Grant I. (2002). Nonacute (Residual) neuropsychological effects of cannabis use: A qualitative analysis and systemic review. Journal of Clinical Pharmacology, 42, 48S-57S. PMID: 12412836 2. Gonzalez, R., Jacobus, J., & Martin, E.M. (2005). Investigating neurocognitive features of hepatitis C virus infection in drug users: potential challenges and lessons learned from the HIV literature. Clinical Infectious Diseases. 41, S45 – S49. PMID: 16265613 3. Gonzalez, R. (2007). Acute and non-acute effects of cannabis on brain functioning and neuropsychological performance. Neuropsychology Review, 17, 347 – 361. PMID: 17680367 4. Gonzalez, R. & Cherner, M. (2008). Co-factors in HIV neurobehavioral disturbances: Substance abuse, Hepatitis C, and aging. International Review of Psychiatry, 20. 49 – 60. PMID: 18240062 5. *Schuster, R.M. & Gonzalez, R. (2012). Substance abuse, hepatitis C, and aging in HIV: Common co-factors that contribute to